title: Is there a role for 15-lipoxygenase in atherogenesis?
abstract: 15-Lipoxygenase has been suggested to play a role in atherogenesis. The proposed action of this enzyme is to oxidize low density lipoprotein (LDL) to the extent that LDL becomes a ligand for the macrophage scavenger receptor. 15-Lipoxygenase and oxidized LDL are co-localized in atherosclerotic lesions; antioxidant drugs that block the lipoxygenase also block oxidation of LDL and the progression of experimental atherosclerosis. Biochemical experiments have demonstrated that the lipoxygenase can be induced by cytokines and/or another factor(s) associated with hypercholesterolemia. However, molecular biological work has shown that induction of the enzyme alone is not sufficient to induce lesion formation. Furthermore, the mechanism of action of 15-lipoxygenase in atherogenesis remains unclear. Predictions of the stereochemistry of enzyme-oxidized linoleate products appear to conflict with the available data. In fact, most studies have discovered substantial levels of racemic 13-hydroxyoctadecadienoic acid (13-HODE) in arterial lesions rather than the stereochemically pure 13(S)-HODE expected from purified enzyme. The possibility that the generation of products of 15-lipoxygenase metabolism must occur in a specific cellular location and during a brief time window in the development of the disease has been discussed. It is also possible that the true function of the linoleate metabolites is to modulate gene expression and regulate mitogenesis, and that oxidation of LDL may play a secondary role. The advent of transgenic species that both develop atherosclerosis and either fail to express or overexpress the lipoxygenase presents an opportunity to clarify some of these issues in the near future.
authors.affiliation: Department of Pharmacology, Columbia University, New York, NY 10032, USA. sjf1@columbia.edu
authors.forename: S J
authors.initials: SJ
authors.lastname: Feinmark
authors.forename: J A
authors.initials: JA
authors.lastname: Cornicelli
mesh_terms: D000818:Animals; D001093:Arachidonate 15-Lipoxygenase / Q000502:physiology*; D001161:Arteriosclerosis / Q000209:etiology*; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D013237:Stereoisomerism
chemical_list: D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D001093:Arachidonate 15-Lipoxygenase